Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

BACKGROUND: The approved dose of rituximab (RTX) in rheumatoid arthritis is 1000 mg × 2, but some data have suggested similar clinical efficacy with 500 mg × 2. The purpose of this study was to compare the effectiveness of the regular and low doses given as first treatment course. METHODS: Twelve Eu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatzidionysiou, Katerina, Lie, Elisabeth, Nasonov, Evgeny, Lukina, Galina, Hetland, Merete Lund, Tarp, Ulrik, Ancuta, Ioan, Pavelka, Karel, Nordström, Dan C., Gabay, Cem, Canhão, Helene, Tomsic, Matija, van Riel, Piet L. C. M., Gomez-Reino, Juan, Kvien, Tore K., van Vollenhoven, Ronald F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756505/
https://www.ncbi.nlm.nih.gov/pubmed/26883119
http://dx.doi.org/10.1186/s13075-016-0951-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756505/
https://www.ncbi.nlm.nih.gov/pubmed/26883119
http://dx.doi.org/10.1186/s13075-016-0951-z

Ejemplares similares